Alec van Gelder

Alec joined Novo Nordisk in August 2025 as Vice President, Corporate Affairs, Rare Disease. He brings over 15 years of experience in the healthcare industry, having worked with AstraZeneca and most recently, Boehringer Ingelheim. Alec’s international background spans the US, Europe, Asia, and Africa, where he has significantly shaped healthcare policy in both developed and emerging markets.

Alec was elected to the NNHF Council in 2026.


Our team